-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Naq5+848f+rnYSrvFdZUneG1sZJEwFCFu1Nlt7yKkwIMkrZbEkuz+Av/84Ik1Fip 2WhFkmkZm9uwr23YT0r2Mg== 0001144204-10-063962.txt : 20101129 0001144204-10-063962.hdr.sgml : 20101129 20101129215559 ACCESSION NUMBER: 0001144204-10-063962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101122 FILED AS OF DATE: 20101129 DATE AS OF CHANGE: 20101129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMATHENE, INC CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 BUSINESS PHONE: 410 269 2600 MAIL ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPPAJOHN JOHN CENTRAL INDEX KEY: 0000897464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 101220502 MAIL ADDRESS: STREET 1: 1660 WALT WHITMAN ROAD STREET 2: SUITE 105 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 v204183_ex.xml X0303 4 2010-11-22 0 0001326190 PHARMATHENE, INC PIP 0000897464 PAPPAJOHN JOHN C/O PHARMATHENE, INC., ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 1 0 0 0 Common Stock 2010-11-22 4 C 0 444044 2.5416 A 444044 I See Footnote Common Stock 911164 D 10% Convertible Note 2.5416 2010-11-22 4 C 0 1128611 D 2011-07-28 Common Stock 444044 0 I See Footnote The 10% Convertible Note (the "Note") reported herein was, and the underlying shares reported herein are, owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of such Note and shares, and this report shall not be deemed an admission that the reporting person was or is the beneficial owner of the Note or shares for purposes of Section 13(d) or Section 16 of the Exchange Act or for any other purpose. The Note, including accrued interest thereon through 11/3/2010, was convertible into the Issuer's Common Stock at a price of $2.541667 per share. Immediately. This Note, together with a Warrant, was received pursuant to a Note and Warrant Purchase Agreement dated as of July 24, 2009, as amended on July 26, 2009 and July 28, 2009, by and among the Issuer and certain noteholders, all as more specifically reported on Form 4 filed with the Securities & Exchange Commission on July 30, 2009. /s/ Roland S. Chase, attorney in fact 2010-11-29 -----END PRIVACY-ENHANCED MESSAGE-----